Eli Lilly and Company (LLY) vs Microsoft Corporation (MSFT)
See how Eli Lilly and Company and Microsoft Corporation differ across market data and performance, so you can decide which asset best fits your strategy.
$1,156.73
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page$507.29
NasdaqGS
Microsoft Corp develops and licenses software for both consumer and enterprise markets. The company is best known for its Windows operating systems and Office productivity applications. Its business is organized into three broadly equal segments: Productivity and Business Processes, which includes legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, and Dynamics; Intelligent Cloud, which includes Azure infrastructure- and platform-as-a-service offerings, Windows Server, and SQL Server; and More Personal Computing, which includes Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktop devices.
View Full PageKey Metrics Comparison
Eli Lilly and CompanyLLY
Market Cap$1.032T
Price$1,156.73
24h Change-1.52%
24h Volume$3.03M
Employees50,000
Shares Outstanding944,818,881
Microsoft CorporationMSFT
Market Cap$3.767T
Price$507.29
24h Change-1.22%
24h Volume$26.64M
Employees228,000
Shares Outstanding7,428,434,704
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
LLY
21.5%MSFT
78.5%Volume Share
Share of combined 24h volume
LLY
10.2%MSFT
89.8%24h Performance
Price change over last 24 hours
LLY
-1.52%MSFT
-1.22%Price Comparison
Eli Lilly and Company
Microsoft Corporation